News Center - Suzhou BG Bio-tech Co., Ltd.

CN/EN

Search

Service Hotline

Phone

13812608481 / 15062670969
Add

5th Floor, Building 11, No. 69 Jiepu Road, Suzhou Industrial Park, Jiangsu Province

Online Consultation

Contact us now to learn more about our services.

Service Hours
Monday–Friday, 8:00–17:00 GMT+8

News Center

About Us

News Center

FDA Approves Regeneron’s Gene Therapy for Hereditary Hearing Loss, Otarmeni

On April 23, 2026, the FDA approved Otarmeni, manufactured by Regeneron, for the treatment of hereditary hearing loss. Getty ImagesFor individuals suffering from a rare form of hereditary deafness, tr

Learn more

2026-04-23
Moderna Launches Late-Stage Clinical Trials for mRNA Bird Flu Vaccine

Moderna, a manufacturer of messenger RNA (mRNA) therapeutics, announced on April 21, 2026, that it is launching trials for an avian flu vaccine. Image source: Maddie Meyer via Getty Images.Dive Brief:

Learn more

2026-04-22
Serif Announces Development of "Modified DNA" (modDNA) Therapy Platform

A scientist at Serif prepares samples for an experiment evaluating the company's "modified DNA" technology. Image courtesy of Serif Biosciences.Flagship Pioneering has launched a new bio

Learn more

2026-04-21
Kyverna Plans to Seek FDA Approval for Its CAR-T Therapy (Stiff Person Syndrome)

According to research results released on Tuesday, a one-time, personalized cell therapy developed by Kyverna Therapeutics has improved mobility and reduced disability levels in patients suffering fro

Learn more

2026-04-21
Revolution Medicines' KRAS Inhibitor Data Impresses

You are reading the web version of STAT’s pop-up newsletter, "AACR in 30 Seconds"—a guide to the annual meeting of the American Association for Cancer Research. Click here to subscribe.The m

Learn more

2026-04-21
Lilly Acquires Kelonia for Up to $7 Billion, Doubling Down on In Vivo Cell Therapy

Some cell therapies have been genetically engineered to target a protein called BCMA, which is present on multiple myeloma cells. Getty ImagesEli Lilly agreed on Monday to acquire the privately held b

Learn more

2026-04-20
UCB Acquires Neurona for $1.2 Billion

Neurona Therapeutics is conducting early-stage cell therapy trials for a form of treatment-resistant epilepsy. Image courtesy of EQT Life Sciences.Through an acquisition announced on Friday, the Belgi

Learn more

2026-04-17
Detailed Rules for Regulation No. 818 and the End-to-End Process for Cell Therapy IITs

To All Relevant Units:Recently, the National Health Commission (NHC) issued the *Guidelines for the Filing of Clinical Research on New Biomedical Technologies*. Serving as the implementing rules for t

Learn more

2026-03-18
Ruihongdi Pharmaceuticals Receives Clinical Approval for Cell Therapy (Including mRNA Technology Platform)

On September 2, 2025, RGL-305 Injection (hereinafter referred to as "RGL-305")—the first cell therapy product targeting malignant tumors independently developed by Shanghai Ruihongdi Pharmac

Learn more

2025-09-03

Copyright © Suzhou BG Bio-tech Co., Ltd. All rights reserved Powered by Bomin